December 8, 2025BloodOpen Access

Anatomical localization-based analysis of de novo secondary cns lymphoma

View Full Paper

Ask AI

Bookmark

Authors

YWYucai WangMayo Clinic AKArushi Khurana RKRebecca L. KingMayo Clinic in Arizona

Discussion

Member takes

Implication

Observational analysis identified B-cell lymphoma subtypes with defined progression-free survival and risk stratification outcomes for patients with CNS lymphoma.

Key Points

Progression-free survival was linked to B-cell lymphoma subtypes, indicating differing prognoses and treatment responses.
Patients receiving autologous stem cell transplant showed potential improved outcomes, particularly in the parenchymal subgroup.
Analysis included 34 patients treated with various regimens, enhancing understanding of clinical approaches to CNS lymphoma.
Risk stratification may be essential for future treatment guidelines in managing de novo secondary CNS lymphoma cases.

Cite This Study

Wang et al. (2025) studied this question.

synapsesocial.com/papers/69362f3d4fa91c937236d4be https://doi.org/10.1182/blood-2025-3675

View Full Paper

Ask AI

Bookmark

Implication

Observational analysis identified B-cell lymphoma subtypes with defined progression-free survival and risk stratification outcomes for patients with CNS lymphoma.

Anatomical localization-based analysis of de novo secondary cns lymphoma

Discussion

Member takes

Implication

Key Points

Cite This Study

Anatomical localization-based analysis of de novo secondary cns lymphoma

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider